1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Force Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY SOURCE
5.1. Introduction
5.2. Synthetic
5.3. Semi-Synthetic
5.4. Natural
6. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY INDICATION
6.1. Introduction
6.2. Cardiovascular
6.3. Renal Disease
6.4. Aneurysms
6.5. Others
7. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY END-USER
7.1. Introduction
7.2. Hospital & Clinics
7.3. Ambulatory Surgical Centers
8. GLOBAL VASCULAR GRAFT MARKET ANALYSIS, BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Source
8.2.2. By Indication
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. United States
8.2.4.2. Canada
8.2.4.3. Mexico
8.3. South America
8.3.1. By Source
8.3.2. By Indication
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.2. Argentina
8.3.4.3. Others
8.4. Europe
8.4.1. By Source
8.4.2. By Indication
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. UK
8.4.4.2. France
8.4.4.3. Germany
8.4.4.4. Italy
8.4.4.5. Others
8.5. Middle East and Africa
8.5.1. By Source
8.5.2. By Indication
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.2. Israel
8.5.4.3. Others
8.6. Asia Pacific
8.6.1. By Source
8.6.2. By Indication
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. Japan
8.6.4.2. China
8.6.4.3. India
8.6.4.4. Australia
8.6.4.5. South Korea
8.6.4.6. Thailand
8.6.4.7. Taiwan
8.6.4.8. Indonesia
8.6.4.9. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Market Share Analysis
9.4. Vendor Competitiveness Matrix
10. COMPANY PROFILES
10.1. Getinge Group
10.2. W.L. Gore & Associates
10.3. B. Braun Melsungen AG
10.4. LeMaitre Vascular Inc.
10.5. Abbott Laboratories
10.6. Cook Medical
10.7. Terumo Medical Corporation
10.8. Cryolife
10.9. Medtronic PLC
10.10. Endologix Inc.